Industry News
News for Providers
Top stories summarized by our editors
9/20/2021

A free webinar that will stream from noon to 1 p.m. Central time Oct. 21 will cover how dentists can help reduce the opioid crisis and the relationship between treatments for acute pain and substance use and addiction, ADA News reported. The webinar will be led by Sharon Parsons, D.D.S., and David Kimberly, D.D.S., M.D., both past presidents of the Ohio Dental Association. "Our understanding of pain relief has progressed tremendously over the last decade even as the opioid crisis has continued to plague our nation," said Dr. Kimberly, an oral surgeon. "Dentists have taken a major role in changing the way we treat acute pain and Dr. Parsons and I are excited to share what we have learned." Participants can earn one hour of continuing education credit.

Full Story:
ADA News
More Summaries:
Dr. Kimberly
9/20/2021

ADA News reported that the Commission on Dental Accreditation approved a plan allowing the College of Dental Medicine at Roseman University of Health Sciences in South Jordan, Utah, to shorten its four-year dental degree program to three years. "We have worked diligently over the past several years to develop and foster a team-based clinical education model ... to create curricular efficiencies that allow students to obtain more classroom and clinical contact hours in less time," said Frank Licari, D.D.S., dean of the Roseman University College of Dental Medicine. The new curriculum will begin with the 2022-23 academic year and is expected save dental students about $130,000 in reduced tuition and living expenses. Roseman is the second dental school in the US to adopt a three-year program.

Full Story:
ADA News
More Summaries:
Roseman
9/20/2021

A CDC committee advising the FDA voted to recommend a booster dose of COVID-19 vaccine for people at risk for severe COVID-19 -- including those with occupational risks such as health care workers -- and for those ages 65 and older, Reuters reported. Panel members did not support widespread administration of boosters, citing insufficient supporting evidence, and said more safety data is needed, especially about risks of post-vaccination heart inflammation in younger people.

Full Story:
Reuters
More Summaries:
Reuters
9/20/2021

Entrepreneur and Dallas Mavericks owner Mark Cuban shared his virtual colonoscopy experience in a tweet last week and urged followers to consider undergoing CT colonography, saying that the procedure only took 30 minutes and "was EASY." The post garnered likes and attention from radiologists, including the ACR. "Thanks for sharing your experience with #CTColonography, Mark!" the ACR wrote in a Twitter post Friday.

Full Story:
Radiology Business
More Summaries:
Twitter
9/20/2021

A study suggested that adenosine A2a receptors are responsible for blood brain flow regulation during rapid eye movement sleep, according to a study found in Cell Reports. The findings may have implications for the development of treatments for neurodegenerative diseases.

Full Story:
Digital Journal
9/20/2021

Researchers have found that treatment of sickle cell anemia using hydroxyurea could reverse heart abnormalities, such as diastolic dysfunction and enlargement of the heart, in 3-year-old to 22-year-old patients, according to findings published in the journal Blood Advances. The findings were based on data from 100 young patients with sickle cell disease, 60 of whom were being given hydroxyurea, with results indicating that cardiac outcomes were better among those treated with hydroxyurea in the long term.

Full Story:
HealthDay News
9/20/2021

CVS Health will employ up to 25,000 new full-time, part-time and temporary health care and retail employees to gear up for flu season, the retailer said Monday. CVS and other pharmacy retailers, including Walgreens Boots Alliance, are expecting a busier than usual winter season as consumers over age 65 get COVID-19 booster shots.

More Summaries:
Walgreens Boots Alliance
9/20/2021

AstraZeneca and Daiichi Sankyo released data from a comparative study assessing their antibody drug conjugate Enhertu, or fam-trastuzumab deruxtecan-nxki, in late-stage breast cancer. Data showed Enhertu lowered the risk of death or disease progression by 72%, compared with Roche's Kadcyla, or trastuzumab emtansine, in patients with HER2-positive metastatic breast cancer. Enhertu posted an overall response rate of 79.7%, compared with 34.2% for Kadcyla.

More Summaries:
Roche
9/20/2021

More dentists are offering membership plans to help patients who do not have dental insurance get needed oral health care they otherwise might not be able to afford, Kaiser Health News reported. KHN interviewed David White, D.D.S., who has offices in Reno and Elko, Nevada. Dr. White, who is chair of the ADA Council on Government Affairs, said about 250 of his patients have signed up for an in-office plan, which has led to increased visits for routine exams and necessary treatment. "It's pushing patients toward better oral health," Dr. White said.
A recent ADA Health Policy Institute survey of 70,000 US dentists showed about 25% offer membership plans, which for a fee generally provide some free preventive care and discounts on dental services. Dave Monahan, CEO of Pennsylvania-based Kleer, which helps dentists set up membership plans, said interest in the plans among dentists has increased during the COVID-19 pandemic as they faced higher costs and more patients did not have employer-based insurance coverage.

Full Story:
Kaiser Health News
More Summaries:
Dr. White
9/20/2021

The administration is adding an extra 30 days to the annual open enrollment period for Affordable Care Act health care coverage, Forbes reported. The fall enrollment period this year will run from Nov. 1 through Jan. 15, 2022.